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Genome engineering
The bacterially derived CRISPR–Cas9 system has proven use-
ful for genome editing in Drosophila, Caenorhabditis elegans, 
zebrafish, mouse, rat, and humans. Recently, Wu and colleagues 
successfully employed this system to correct a mutant gene in 
mice. In a mouse model of dominant cataract disorder caused by 
a defined mutation in the Crygc gene, the CRISPR–Cas9 system, 
which involves injection of the Cas9 mRNA and single-guide 
RNAs that target the mutant allele into zygotes, successfully and 
functionally corrected the heterozygous mutation via homology-
directed repair. In several cases, however, nonhomologous end 
joining–based deletions or insertions were utilized in this process 
to functionally repair the gene. Importantly, only rare instances 
of off-target mutations were detected, and the pups were able to 
transmit the corrected allele to their progeny. Thus, the CRISPR–
Cas9 system can be used to cure a genetic disease in mice, and 
these findings pave the way for exploration of use of this strategy 
for mutation correction in a human disease setting. (Cell Stem 
Cell 13:659–62, 2013) Selected by M. Amagai
The dangers of light skin
Low levels of melanin are correlated with the development of 
angiogenic ocular and skin diseases. Because intracellular pig-
ment levels in retinal pigment epithelium cells are similar in all 
races, Adini and colleagues investigated the role of melanocytes 
in regulating angiogenesis in pigmented tissues in numerous 
wild-type and albino mouse models. These investigators found 
that melanocytes secrete fibromodulin, a previously unknown 
angiogenic factor that functions as a potent stimulator of endo-
thelial cell growth, migration, sprouting, and capillary network 
formation. In addition, fibromodulin stimulated blood ves-
sel formation and induced neovascularization in these mice. 
Mechanistically, fibromodulin was found to activate endothelial 
cells via transforming growth factor β-1, which ultimately initi-
ates the SMAD pathway. These findings, which illuminate the 
mechanism of epidemiological correlation between fair skin and 
susceptibility to angiogenic disease, suggest that fibromodulin is 
a potential therapeutic target for treatment of pathological angio-
genesis. (J Clin Invest 124:425–36, 2014) Selected by T. Schwarz
UV promotes metastatic progression
Although UV radiation is known to induce tumor-initiating 
genomic alterations in melanocytes, additional microenviron-
mental effects of UV radiation in melanoma pathogenesis are 
not well understood. Bald and colleagues recently demonstrated 
that repetitive UV exposure promoted metastatic progression in a 
mouse model in a manner that is independent of its tumor-initi-
ating effects. Following repetitive irradiation of mice with estab-
lished melanomas, the number of lung metastases, but not the 
incidence, multiplicity, or growth of the tumors, was increased. 
More specifically, UV irradiation promotes melanocyte peri-
vascular expansion and metastatic dissemination via Toll-like 
receptor 4 (TLR4)/myeloid differentiation primary response gene 
88 (MYD88)–driven neutrophilic inflammation, and this effect 
was directly initiated by high-mobility group box 1 (HMGB1) 
release from UV-damaged keratinocytes. These models offer new 
avenues for exploration of the mechanisms governing recipro-
cal melanoma–endothelial cell interactions and offer guidance 
for development of melanoma treatments that impair metastatic 
tumor progression via inhibition of neutrophilic inflammation 
driven by HMBG1 and/or the TLR4/MYDD88 signaling pathway. 
(Nature 507:109–13, 2014) Selected by T. Schwarz
Ready, set, neutrophil
Neutrophils are required for control and clearance of infec-
tion, including infection by the prevalent bacterial pathogen 
Staphylococcus aureus; however, the mechanisms of neutrophil 
homing from the bloodstream and subsequent interstitial migra-
tion after barrier breach are not well defined. Abtin and colleagues 
recently discovered that perivascular macrophages, which were 
previously not known to be involved in this process, produce che-
moattractants that biochemically guide the neutrophils to the cuta-
neous interstitial space. Furthermore, these studies revealed that S. 
aureus directly hinders this neutrophil extravasation by destruction 
of the neutrophils via a pathway dependent on the primary patho-
gen-secreted cytotoxin α-hemolysin. Thus, S. aureus specifically 
targets these cells and diminishes the production of homing cyto-
kines, extending the time before a successful immune response 
is mounted and allowing the bacteria time to proliferate. These 
findings indicate a critical role for nonendothelial blood vessel–
associated cells in leukocyte extravasation and underscore the 
importance of the innate immune response in infection clearance. 
(Nat Immunol 15:45–53, 2014) Selected by T. Schwarz
Easy on the stomach
No single etiology has been identified for the inflammatory 
bowel diseases (IBD) Crohn’s disease and ulcerative colitis, but 
predisposing genetic and environmental factors have been impli-
cated. Previous studies showed that antibiotics, nonsteroidal 
anti-inflammatory drugs, and hormone therapy are associated 
with an increased risk of IBD, and some cases of IBD following 
isotretinoin therapy have been reported. The vitamin A analog 
isotretinoin is widely prescribed to treat severe acne; therefore, 
whether such a risk is inherent in patients treated with isotreti-
noin is an important issue to address. In a large case–control 
study using the French National Health Insurance database of 
7,593 cases of IBD and 30,372 controls, Racine and colleagues 
found no association between isotretinoin exposure and ulcer-
ative colitis risk but identified an inverse association between 
isotretinoin exposure and Crohn’s disease. These data support 
the safe use of isotretinoin for treatment of severe acne. (Am J 
Gastroenterol 109:563–9, 2014) Selected by H. WilliamsJournal of Investigative Dermatology (2014) 134, 1785. doi:10.1038/jid.2014.212
